Ventyx Biosciences Announces Executive Financial Officer Changes

Ventyx Biosciences (VTYX) has issued an announcement.

Ventyx Biosciences, Inc. has appointed Roy M. Gonzales as the interim principal financial officer and interim principal accounting officer, following Martin D. Auster, M.D.’s departure. Gonzales brings extensive experience from previous finance roles in various life sciences and medical device companies. His compensation remains unchanged with a $350,000 base salary and potential for a 30% bonus. Dr. Auster’s exit includes a severance package with continued salary, health coverage, and accelerated equity vesting, subject to the terms of their separation agreement.

For an in-depth examination of VTYX stock, go to TipRanks’ Stock Analysis page.